Targeted Therapy and Avelumab in Merkel Cell Carcinoma
Clinical trial NCT04261855 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04261855
- Sponsor
- Melanoma and Skin Cancer Trials Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-08
- Primary completion
- 2026-12-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.